Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-02-16

FDA Approved: NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL — Supplemental Application (Nivagen Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for norethindrone acetate and ethinyl estradiol from Nivagen Pharmaceuticals, a combined oral contraceptive.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Norethindrone acetate and ethinyl estradiol (Norethindrone acetate and ethinyl estradiol)

Snippet

SUPPL AP for NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL)